These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35642341)

  • 1. Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
    Xu ZJ; Jin Y; Zhang XL; Xia PH; Wen XM; Ma JC; Lin J; Qian J
    Cancer Med; 2023 Jan; 12(1):789-807. PubMed ID: 35642341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia.
    Zhuang H; Li F; Si T; Pei R; Yu M; Chen D; Ye P; Lu Y
    Acta Haematol; 2023; 146(3):196-205. PubMed ID: 36746134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia.
    Sun X; Huang S; Wang X; Zhang X; Wang X
    Oncotarget; 2018 Jun; 9(44):27574-27584. PubMed ID: 29938007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the
    Xu ZJ; Zhang XL; Jin Y; Wang SS; Gu Y; Ma JC; Wen XM; Leng JY; Mao ZW; Lin J; Qian J
    Mol Ther Oncolytics; 2022 Sep; 26():88-104. PubMed ID: 35795094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker.
    Wu Z; Liu X; Xie F; Ma C; Lam EW; Kang N; Jin D; Yan J; Jin B
    Life Sci; 2024 Apr; 343():122527. PubMed ID: 38417544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
    Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
    Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
    BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia.
    Cheng Y; Yang X; Wang Y; Li Q; Chen W; Dai R; Zhang C
    BMC Med Inform Decis Mak; 2024 Jan; 24(1):2. PubMed ID: 38167056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal monitoring of minimal residual disease in acute myeloid leukemia.
    Coustan-Smith E; Song G; Shurtleff S; Yeoh AE; Chng WJ; Chen SP; Rubnitz JE; Pui CH; Downing JR; Campana D
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720577
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ke P; Bao X; Liu C; Zhou B; Huo M; Chen Y; Wang X; Wu D; Ma X; Liu D; Chen S
    Transl Cancer Res; 2022 Oct; 11(10):3491-3505. PubMed ID: 36388050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of immune checkpoints in acute myeloid leukemia.
    Chen C; Liang C; Wang S; Chio CL; Zhang Y; Zeng C; Chen S; Wang C; Li Y
    J Hematol Oncol; 2020 Apr; 13(1):28. PubMed ID: 32245463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
    Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
    Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
    Zhu R; Tao H; Lin W; Tang L; Hu Y
    Front Oncol; 2020; 10():574939. PubMed ID: 33330048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.